Elevated serum levels of endostatin have been found in metastatic cancer patients (Feldman et al, 2002) and have been correlated to the clinical course of the disease and to tumour vascularity in various tumour types (Bono et al, 2003). Here, COL18A1 is linked to metastatic malignant neoplasm.